AstraZeneca: all 4,196 studies
Page 28 of 42. Open to participants first (299), then studies with results posted, then the rest; newest registration first within each.
- Study Evaluating Absorption, Distribution, Metabolism and Excretion (ADME) of Single Dose [14C] Selumetinib in VolunteersCompletedNCT01931761Phase 1
- A Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD0914CompletedNCT01929629Phase 1
- Study to Assess the Effect of Rifampicin (CYP Inducer) on Blood Levels and Safety of Olaparib in Patients With Advanced Solid TumoursCompletedNCT01929603Phase 1
- Longitudinal Study of Patients With Opioid-Induced ConstipationCompletedNCT01928953
- RDEA3170 Monotherapy in Subjects With GoutCompletedNCT01927198Phase 2
- AZD6423 SAD/MAD Study in Healthy VolunteersCompletedNCT01926366Phase 1
- Prilosec Bioequivalence Study in Healthy VolunteersCompletedNCT01921920Phase 1
- To Determine the Effect of Food on the Pharmacokinetics of Olaparib and the Effect of Olaparib on QT Interval Following Oral Dosing of a Tablet Formulation in Patients With Advanced Solid TumoursCompletedNCT01921140Phase 1
- Comparative Effectiveness of Symbicort vs. Advair Among COPD PatientsCompletedNCT01921127
- Comparative Effectiveness of Symbicort vs. Spiriva Among COPD PatientsCompletedNCT01917643
- A Phase 1 Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Immunogenicity of MEDI9929 After Single Administration in Healthy Male Japanese SubjectsCompletedNCT01913028Phase 1
- RDEA3170 AME StudyCompletedNCT01910506Phase 1
- Lesinurad Interaction Study With RanitidineCompletedNCT01908257Phase 1
- To Assess the Effect of Itraconazole (a CYP3A4 Inhibitor) on the Pharmacokinetics of Olaparib, and the Effect of Olaparib on QT Interval Following Oral Dosing of a Tablet Formulation to Patients With Advanced Solid TumoursCompletedNCT01900028Phase 1
- Dyslipidemia Management in Chinese Post Stroke PatientsCompletedNCT01897883
- Study to Investigate the Safety Profile of AZD4721 After Single Doses at Different Dose LevelsCompletedNCT01889160Phase 1
- Cardiovascular Risk Stratification of Ambulatory Patients in Primary PreventionCompletedNCT01889030
- Risk of Uncomplicated Peptic Ulcer in the General PopulationCompletedNCT01888588
- Assessment of Low-dose ASA Discontinuation Risk Associated With Concomitant PPI Use During the First Year of ASA TherapyCompletedNCT01888575
- Prevalence and Risk Factors in Unipolar Depression Patients Without Remission After One Antidepressant TrialCompletedNCT01887639
- Study to Investigate if the Uptake of Ticagrelor Into the Body Differs Depending on Method of Administration.CompletedNCT01887626Phase 1
- AZD8186 First Time In Patient Ascending Dose StudyCompletedNCT01884285Phase 1
- NSAID Drug Interaction StudyCompletedNCT01884272Phase 1
- Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ALXN1007 in Healthy Male and Female SubjectsCompletedNCT01883544Phase 1
- RDEA3170 and Febuxostat Drug Interaction StudyCompletedNCT01883167Phase 1
- Study to Assess the Safety, Tolerability, and Pharmacokinetics of AMP-110 in Subjects With Rheumatoid ArthritisCompletedNCT01878123Phase 1
- An Open-Label Study Examining the Long-Term Safety of Exenatide Given Twice Daily to Patients With Type 2 Diabetes MellitusCompletedNCT01876849Phase 3
- Bioequivalence StudyCompletedNCT01874080Phase 1
- Single and Multiple Dose Study in Japanese SubjectsCompletedNCT01872832Phase 1
- Long-Term rIsk, Clinical manaGement and Healthcare Resource Utilization of Stable CAD in Post MI PatientsTerminatedNCT01866904
- D081AC00001 Food Interaction With Olaparib Capsule in Patients With Solid TumoursCompletedNCT01851265Phase 1
- Gefitinib Usage and Outcomes in Routine TreatmentCompletedNCT01818947
- To Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Doses AZD8848 in Healthy SubjectsCompletedNCT01818869Phase 1
- Specific Clinical Experience Investigation for Long-term Use of Exenatide (Byetta Subcutaneous Injection)CompletedNCT01817569
- The Risk of Uncomplicated Peptic Ulcer in a Cohort of Secondary Prevention Aspirin UsersCompletedNCT01814943
- Lesinurad and Allopurinol Combination Extension Study in GoutCompletedNCT01808131Phase 3
- Retrospective Study in a NSCLC M+ pCompletedNCT01795352
- A Two-part Multiple Dose Study to Assess the Safety and Effects of AZD3293 in Healthy Elderly and Alzheimer's PatientsCompletedNCT01795339Phase 1
- Physician Survey on Monitoring of Patients Treated With QuetiapineCompletedNCT01795326
- EMR Data to Assess Monitoring of Patients Treated With QuetiapineCompletedNCT01793324
- Extension Study for 2993-112CompletedNCT01789957Phase 3
- Acid-suppressing Drugs Pregnancy Asthma Offspring StudyCompletedNCT01787435
- The Asthma Control Rate Achieved by Budesonide/Formoterol in Clinical Practice in ChinaCompletedNCT01785901
- Europe-Japan Diagnostic Study for EGFR TestingCompletedNCT01785888
- Level of Concordance Between Patients Perception and Physicians Evaluation of Cardiovascular RiskCompletedNCT01781416
- A Retrospective, Observational, Non-interventional Trial to Assess Eculizumab Treatment Effect in Patients With Atypical Hemolytic Uremic Syndrome (aHUS)CompletedNCT01770951
- Observation Study of the Clinical Management of Bipolar DisorderCompletedNCT01770704
- A Phase 1 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of MEDI4893 in Healthy Adult SubjectsCompletedNCT01769417Phase 1
- Centralised Pan-Algerian Survey on the Undertreatment of HypercholesterolemiaCompletedNCT01768403
- A Human Phase I Absolute Bioavailability Study of PRT054021 in Healthy Male VolunteersCompletedNCT01765868Phase 1
- An Open-Label, Single-Dose, Mass-Balance Study to Assess the Disposition of 14C-Labeled PRT054021 in Healthy Male SubjectsCompletedNCT01765855Phase 1
- Canadian Ticagrelor SurveyCompletedNCT01757483
- The Safety and Efficacy of Eculizumab in Japanese Patients With Atypical Hemolytic Uremic Syndrome (aHUS)CompletedNCT01757431Phase 2
- A Clinical Study of Safety and P2Y12 Receptor Inhibition Effects of Ticagrelor and Clopidogrel in Vietnamese PatientWithdrawnNCT01757262Phase 3
- A Bioequivalence Study of the Fixed Dose Combinations of Saxagliptin/Metformin XR Relative to Co-AdministrationCompletedNCT01755494Phase 1
- To Characterize the Safety and Tolerability of Eculizumab in Two Japanese aHUS PatientsCompletedNCT01755429
- A First Time in Man Study to Asses the Safety and Tolerability of AZD7624 in Healthy SubjectsCompletedNCT01754844Phase 1
- Korean Post-marketing Surveillance for Kombiglyze XR®CompletedNCT01754142
- Perception of Symptom Variability in COPDCompletedNCT01753427
- Oxis 9mcg Turbuhaler Clinical Experience InvestigationCompletedNCT01749462
- Single and Multiple Dose Study in JapaneseCompletedNCT01744379Phase 1
- Acid Suppressing Drug Seizure Epidemiology StudyCompletedNCT01744301
- Study to See if Platelet Transfusion Stop or Lessen the Effect of the Drug on PlateletsCompletedNCT01744288Phase 1
- A Single Dose Study to Assess the Safety, Effects, and Blood and Urine Drug Levels of AZD3293 in Healthy SubjectsCompletedNCT01739647Phase 1
- Phase I Study to Assess the Effect on Healthy Male Volunteers of Ketoconazole on the Pharmacokinetics of a Single Dose of AZD5069 Administered Orally.CompletedNCT01735240Phase 1
- Nexium Capsules LDA Specific Clinical Experience InvestigationCompletedNCT01729182
- Better Diabetes Control, Quality - Educate to Achieve Compliance.CompletedNCT01728714
- Assess the Pharmacokinetics of Rosuvastatin and Simvastatin When Administered Alone or in Combination With FostamatinibCompletedNCT01725230Phase 1
- Management of Metastatic Breast Cancer in Clinical Practice - Retrospective StudyCompletedNCT01715155
- Symbicort Turbuhaler 30/60 Special Clinical Experience Investigation for Long-term Use for Chronic Obstructive Pulmonary Disease (COPD) PatientsCompletedNCT01713075
- Clinical Experience Investigation of Symbicort Turbuhaler as Maintenance Therapy and Reliever TherapyCompletedNCT01711840
- Epidemiology and Management of Metastatic Breast CancerCompletedNCT01711502
- Effect of Different Fixed Pramlintide:Insulin Dose Ratios on Postprandial Glucose in T1DMCompletedNCT01708044Phase 1
- Correlation Between Patient Perception and Findings on Clinical Examination in Chronic Obstructive Pulmonary Disease (COPD) PatientsCompletedNCT01703416
- Multicenter Study of Antimicrobial Resistance of Gram-positive and Gram-negative Clinical Strains to Ceftaroline and Other Antimicrobials in RussiaCompletedNCT01700842
- OPtimal Type 2 dIabetes Management Including Benchmarking and Standard Treatment in CEEMEACompletedNCT01694758
- Investigating Safety, Tolerability and Efficacy of AZD5363 in Prostate Cancer.CompletedNCT01692262Phase 1
- Description of the Use of Quetiapine Extended Release (XR) in Real-life Practice in France. An Observational StudyCompletedNCT01689389
- Assess Pharmacokinetics of Fostamatinib in Fed and Fasted State in Combination With Ranitidine to Assess BioavailabilityCompletedNCT01682408Phase 1
- Sicilian Administrative Data Base Study in Acute Coronary Syndrome PatientsWithdrawnNCT01678339
- A Study in Healthy Subjects to Investigate Pharmacokinetics of AZD8683 When Administered in Different WaysWithdrawnNCT01666613Phase 1
- Evaluation of Sub-syndromal Symptoms After Acute Depressive Episode in Bipolar DisorderTerminatedNCT01663974
- Validation of Questionnaire and Assessment of Patient Satisfaction for Budesonide/Formoterol Fix Combination Dry Powder Inhalers (DPI) in Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT01646424
- Assessing a Stool Symptom Screener in Patients With Chronic Opioid-Induced ConstipationCompletedNCT01645371
- A Study to Assess the Bioequivalence of R406 in Healthy Volunteers When Given 100mg and 150 mg of FostamatinibCompletedNCT01645085Phase 1
- To Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Ascending Doses of Inhaled AZD7594CompletedNCT01636024Phase 1
- A Study in Healthy Subjects to Investigate Pharmacokinetics of AZD5423 When Administered in Different WaysCompletedNCT01635985Phase 1
- Prevalence of Gastroesophageal Reflux Disease (GERD) in Patients With Upper Gastrointestinal Tract Symptoms in EgyptCompletedNCT01635959
- A Randomized, Open Label Study to Compare the Current Phase II and Planned Phase III Capsule Formulation of AZD6244CompletedNCT01635023Phase 1
- CorRELation Between PatIent PErception and Findings on Clinical ExaminationCompletedNCT01627743
- Observational Study to Understand Patients' and Physicians' Attitudes to Statins in TurkeYCompletedNCT01625884
- Open Label, Healthy Volunteers, Bioequivalence Study With NaloxegolCompletedNCT01623609Phase 1
- Asthma Comparative Effectiveness StudyCompletedNCT01623544
- An Observational Study Evaluating Cholesterol Levels in Patients on Cholesterol Lowering Drugs in Jordan and LebanonCompletedNCT01614561
- Investigation of Specific Protein/Markers in Patients With Osteoarthritis of the Knee Having a Total Knee ReplacementCompletedNCT01611441
- A Post Marketing Surveillance to Evaluate the Safety and Efficacy of BrilintaCompletedNCT01611272
- A Single and Multiple Dose Study to Assess Blood and Urine Drug Levels of Fostamatinib in Healthy Japanese SubjectsCompletedNCT01608542Phase 1
- Centralized Pan-Middle East Survey on the Undertreatment of HypercholesterolemiaCompletedNCT01604733
- A Study to Assess Safety and Tolerability of Oral AZD3241 in Patients With Parkinson's DiseaseCompletedNCT01603069Phase 2
- Study in Healthy Males to Assess Bioavailability of Single Fostamatinib With iv Micro Tracer DoseCompletedNCT01598571Phase 1